Peter Kemp

Peter Kemp, MA, is a British patient advocate for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS] and lyme disease. He has been an outspoken critic of the PACE trial often  dissecting the PACE trial in detail in his blog.

Blog post/articles about PACE trial

 * Oct 01, 2016, The PACE Trial – ‘Illegal’ Participants skew the data
 * Oct 01, 2016, Trial CBT v. SMC''
 * Sep 30, 2016, PACE Trial Chalder Fatigue Questionnaire Data
 * Sep 30, 2016, Protected: Analysing the PACE Trial 6 Minute Walk Test Data
 * Sep 26, 2016, Coercion of Participants in the PACE Trial
 * Sep 23, 2016, The Science Media Centre and the PACE Trial – a deceptive partnership
 * Sep 15, 2016, If Mel Brooks made ‘The Clinical Trial’
 * Sep 14, 2016, PACE Trial Normal Range Fatigue – Another Untenable Construct
 * Sep 14, 2016, PACE Trial SF36PF ‘Improved’. New data shows that the criteria is as useless as ‘Normal Range’
 * Sep 12, 2016, PACE Trial ‘Improvers’
 * Sep 10, 2016, PACE Trial Participants – were they exploited?
 * Sep 10, 2016, The PACE Trial ‘Normal Range’ – an Untenable Construct
 * May 05, 2016, When Simon Wessely shoved a Hans Eysenck scandal under the rug
 * Feb 17, 2016, The PACE Trial: Making up Recovery to suit themselves
 * Feb 2016, The PACE Trial – some personal observations
 * Jun 27 2011, Assumptions, assumptions by Peter Kemp in response to BMJ article, "Dangers of research into chronic fatigue syndrome," doi.org/10.1136/bmj.d3780.

Online presence

 * Blog
 * Twitter
 * Website